A phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)A. Spreafico,F. Janku,J. A. Rodon,A. W. Tolcher, S. R. Chandana,M. Oliva, S. Musalli,L. Knauss,M. Kragh,L. Alifrangis,C. Frohlich, M. C. Melander, T. Blondal,M. W. Pedersen,J. Lantto,D. Wood,P. I. Nadler,I. D. Horak,L. L. Siu,N. LakhaniAnnals of Oncology（2019）引用 9|浏览41暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
